Becton Dickinson Share Holder Equity 2010-2022 | BDX

Becton Dickinson share holder equity from 2010 to 2022. Share holder equity can be defined as the sum of preferred and common equity items
  • Becton Dickinson share holder equity for the quarter ending June 30, 2022 was $25.493B, a 5.63% increase year-over-year.
  • Becton Dickinson share holder equity for 2021 was $23.677B, a 0.37% decline from 2020.
  • Becton Dickinson share holder equity for 2020 was $23.765B, a 12.73% increase from 2019.
  • Becton Dickinson share holder equity for 2019 was $21.081B, a 0.41% increase from 2018.
Becton Dickinson Annual Share Holder Equity
(Millions of US $)
2021 $23,677
2020 $23,765
2019 $21,081
2018 $20,994
2017 $12,948
2016 $7,633
2015 $7,164
2014 $5,053
2013 $5,043
2012 $4,136
2011 $4,828
2010 $5,435
2009 $5,143
Becton Dickinson Quarterly Share Holder Equity
(Millions of US $)
2022-06-30 $25,493
2022-03-31 $24,525
2021-12-31 $24,160
2021-09-30 $23,677
2021-06-30 $24,135
2021-03-31 $24,826
2020-12-31 $24,663
2020-09-30 $23,765
2020-06-30 $24,022
2020-03-31 $20,951
2019-12-31 $21,202
2019-09-30 $21,081
2019-06-30 $21,497
2019-03-31 $21,309
2018-12-31 $21,404
2018-09-30 $20,994
2018-06-30 $21,357
2018-03-31 $21,152
2017-12-31 $21,247
2017-09-30 $12,948
2017-06-30 $12,587
2017-03-31 $7,963
2016-12-31 $7,583
2016-09-30 $7,633
2016-06-30 $8,033
2016-03-31 $7,666
2015-12-31 $7,223
2015-09-30 $7,164
2015-06-30 $7,253
2015-03-31 $7,159
2014-12-31 $5,068
2014-09-30 $5,053
2014-06-30 $5,378
2014-03-31 $5,315
2013-12-31 $5,078
2013-09-30 $5,043
2013-06-30 $4,717
2013-03-31 $4,589
2012-12-31 $4,469
2012-09-30 $4,136
2012-06-30 $4,235
2012-03-31 $4,476
2011-12-31 $4,728
2011-09-30 $4,828
2011-06-30 $5,298
2011-03-31 $5,099
2010-12-31 $4,878
2010-09-30 $5,435
2010-06-30 $5,154
2010-03-31 $5,150
2009-12-31 $5,260
2009-09-30 $5,143
2009-06-30 $5,212
2009-03-31 $4,804
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $72.810B $20.248B
Becton, Dickinson and Company, is a medical technology company engaged principally in the development, manufacture and sale of medical devices, instrument systems and reagents. BD's operations consisted of three business segments: BD Medical, BD Diagnostics and BD Biosciences. The company's organizational structure was realigned to form two principal business segments: BD Medical, BD Life Sciences and BD Interventional. BD Medical: BD Medical's major product lines include needles, syringes and intravenous catheters for medication delivery and generic prefilled injectables. BD Life Sciences - BD Diagnostics provides products for the safe collection and transport of diagnostics specimens to detect a broad range of infectious diseases, healthcare-associated infections and cancer. BD Biosciences produces research and clinical tools that facilitate the study of cells to gain a better understanding of normal and disease processes. With the acquisition of C.R. Bard, BD added a new segment - BD Interventional.
Stock Name Country Market Cap PE Ratio
McKesson (MCK) United States $50.991B 14.81
AmerisourceBergen (ABC) United States $30.314B 13.39
West Pharmaceutical Services (WST) United States $24.398B 37.15
Laboratory Of America Holdings (LH) United States $23.439B 10.25
Cardinal Health (CAH) United States $16.828B 12.92
Cooper (COO) United States $16.065B 24.73
CONMED (CNMD) United States $2.967B 29.25
Invacare (IVC) United States $0.033B 0.00